Last reviewed · How we verify

NCT03980457

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Recruiting now NA Last updated 1 April 2026
What this trial tests

NA trial testing Indego Exoskeleton in Stroke in 50 participants. Currently enrolling.

Timeline
1 September 2021
Primary endpoint
1 September 2026
1 September 2028

Quick facts

Lead sponsorUniversity of Oklahoma
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 September 2021
Primary completion1 September 2026
Estimated completion1 September 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oklahoma

Who can join

Adults 18 to 90, any sex, with Stroke or Weakness of Extremities as Sequela of Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Electromechanical-assisted training for walking after stroke.
    Mehrholz J, Thomas S, Kugler J, Pohl M, et al · · 2020 · cited 146× · PMID 33091160 · DOI 10.1002/14651858.cd006185.pub5

Verify or expand the search:

Other trials of Indego Exoskeleton

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Oklahoma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing